These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16097397)

  • 1. Buprenorphine and methadone in the treatment of opioid dependence: methods and design of the COBRA study.
    Wittchen HU; Apelt SM; Bühringer G; Gastpar M; Backmund M; Gölz J; Kraus MR; Tretter F; Klotsche J; Siegert J; Pittrow D; Soyka M
    Int J Methods Psychiatr Res; 2005; 14(1):14-28. PubMed ID: 16097397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression and Outcomes of Methadone and Buprenorphine Treatment Among People with Opioid Use Disorders: A Literature Review.
    Ghabrash MF; Bahremand A; Veilleux M; Blais-Normandin G; Chicoine G; Sutra-Cole C; Kaur N; Ziegler D; Dubreucq S; Juteau LC; Lestage L; Jutras-Aswad D
    J Dual Diagn; 2020; 16(2):191-207. PubMed ID: 32089124
    [No Abstract]   [Full Text] [Related]  

  • 3. One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy: a nationally representative cohort study in 2694 patients.
    Soyka M; Apelt SM; Lieb M; Wittchen HU
    J Clin Psychopharmacol; 2006 Dec; 26(6):657-60. PubMed ID: 17110826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Buprenorphine vs. methadone as maintenance treatment for opioid dependence].
    Fischer G; Gombas W; Eder H; Jagsch R; Stühlinger G; Aschauer HN; Kasper S
    Nervenarzt; 1999 Sep; 70(9):795-802. PubMed ID: 10522247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index.
    Strain EC; Stitzer ML; Liebson IA; Bigelow GE
    J Clin Psychopharmacol; 1996 Feb; 16(1):58-67. PubMed ID: 8834420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-year mortality rates of patients in methadone and buprenorphine maintenance therapy: results from a nationally representative cohort study.
    Soyka M; Träder A; Klotsche J; Backmund M; Bühringer G; Rehm J; Wittchen HU
    J Clin Psychopharmacol; 2011 Oct; 31(5):678-80. PubMed ID: 21881461
    [No Abstract]   [Full Text] [Related]  

  • 7. Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.
    Nielsen S; Dietze P; Lee N; Dunlop A; Taylor D
    Addiction; 2007 Apr; 102(4):616-22. PubMed ID: 17286641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based treatment for opioid disorders: a 23-year national study of methadone dose levels.
    D'Aunno T; Pollack HA; Frimpong JA; Wutchiett D
    J Subst Abuse Treat; 2014 Oct; 47(4):245-50. PubMed ID: 25012549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)].
    Fhima A; Henrion R; Lowenstein W; Charpak Y
    Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS26-36. PubMed ID: 11435992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching opioid-dependent patients in substitution treatment from racemic methadone, levomethadone and buprenorphine to slow-release oral morphine: Analysis of the switching process in routine care.
    Baschirotto C; Lehmann K; Kuhn S; Reimer J; Verthein U
    J Pharmacol Sci; 2020 Sep; 144(1):9-15. PubMed ID: 32586692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study.
    Lacroix I; Berrebi A; Garipuy D; Schmitt L; Hammou Y; Chaumerliac C; Lapeyre-Mestre M; Montastruc JL; Damase-Michel C
    Eur J Clin Pharmacol; 2011 Oct; 67(10):1053-9. PubMed ID: 21538146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of buprenorphine and methadone in the treatment of opioid dependence.
    Strain EC; Stitzer ML; Liebson IA; Bigelow GE
    Am J Psychiatry; 1994 Jul; 151(7):1025-30. PubMed ID: 8010359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substitution with buprenorphine in methadone- and morphine sulfate-dependent patients. Preliminary results.
    Bouchez J; Beauverie P; Touzeau D
    Eur Addict Res; 1998; 4 Suppl 1():8-12. PubMed ID: 9767200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance agonist treatments for opiate-dependent pregnant women.
    Minozzi S; Amato L; Jahanfar S; Bellisario C; Ferri M; Davoli M
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006318. PubMed ID: 33165953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buprenorphine unobserved "home" induction: a survey of Ontario's addiction physicians.
    Srivastava A; Kahan M; Leece P; McAndrew A
    Addict Sci Clin Pract; 2019 May; 14(1):18. PubMed ID: 31039821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six-Year Outcome of Opioid Maintenance Treatment in Heroin-Dependent Patients: Results from a Naturalistic Study in a Nationally Representative Sample.
    Soyka M; Strehle J; Rehm J; Bühringer G; Wittchen HU
    Eur Addict Res; 2017; 23(2):97-105. PubMed ID: 28376505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom.
    Hickman M; Steer C; Tilling K; Lim AG; Marsden J; Millar T; Strang J; Telfer M; Vickerman P; Macleod J
    Addiction; 2018 Aug; 113(8):1461-1476. PubMed ID: 29672985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buprenorphine and methadone: a comparison of patient completion rates during inpatient detoxification.
    Blondell RD; Smith SJ; Servoss TJ; DeVaul SK; Simons RL
    J Addict Dis; 2007; 26(2):3-11. PubMed ID: 17594993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial.
    Otiashvili D; Piralishvili G; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
    Drug Alcohol Depend; 2013 Dec; 133(2):376-82. PubMed ID: 23916321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Increased Dispensing of Opioid Agonist Therapy Take-Home Doses and Opioid Overdose and Treatment Interruption and Discontinuation.
    Gomes T; Campbell TJ; Kitchen SA; Garg R; Bozinoff N; Men S; Tadrous M; Munro C; Antoniou T; Werb D; Wyman J
    JAMA; 2022 Mar; 327(9):846-855. PubMed ID: 35230394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.